Cutler Group LLC / CA - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$5
-28.6%
4,6000.0%0.00%0.0%
Q2 2023$7
-22.2%
4,6000.0%0.00%0.0%
Q1 2023$9
-43.8%
4,6000.0%0.00%0.0%
Q4 2022$16
-99.6%
4,600
-20.7%
0.00%
Q3 2022$4,000
-20.0%
5,800
-37.5%
0.00%
Q2 2022$5,000
-82.8%
9,276
-70.2%
0.00%
-100.0%
Q1 2022$29,000
-61.8%
31,176
+171.9%
0.00%
-33.3%
Q4 2021$76,000
-29.6%
11,466
-38.7%
0.00%
-40.0%
Q3 2021$108,000
+140.0%
18,700
+156.2%
0.01%
+150.0%
Q2 2021$45,000
+25.0%
7,300
-57.3%
0.00%
+100.0%
Q1 2021$36,000
+800.0%
17,100
+402.9%
0.00%
Q4 2020$4,000
+33.3%
3,400
+240.0%
0.00%
Q3 2020$3,000
-94.9%
1,000
-93.1%
0.00%
-100.0%
Q2 2020$59,000
+90.3%
14,500
+57.6%
0.00%
+100.0%
Q1 2020$31,000
+1450.0%
9,200
+411.1%
0.00%
Q4 2019$2,0001,800
+800.0%
0.00%
Q4 2018$02000.0%0.00%
Q3 2018$02000.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,401,570$14,602,0002.94%
DAFNA Capital Management LLC 1,237,400$7,523,0002.17%
RTW INVESTMENTS, LP 4,902,785$29,809,0000.84%
Kerrisdale Advisers, LLC 453,182$2,755,0000.31%
COWEN AND COMPANY, LLC 300,042$1,824,0000.30%
Artal Group S.A. 1,259,177$7,656,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$27,664,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$1,346,0000.06%
FRANKLIN STREET ADVISORS INC /NC 60,000$365,0000.04%
JENNISON ASSOCIATES LLC 2,625,514$15,963,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders